CD8A and neoplasm: No significant changes were noted for naïve and memory populations between C002- and M002-treated tumors (Supplementary Figures 5I, J), suggesting that CD8(+) T cells in C002-treated tumors may have a less active role in maintaining the anti-tumor response at the time point sampled in this tumor model.